iRadimed Corporation

IRMD Healthcare Medical Devices

iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 8.89% and free cash flow grew 11.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

88.27 1.10 −1.23%
Market cap
$1.1B
P/E
48.5×
Fwd P/E
48.7×
Dividend yield
0.87%
F-score
6/9
Altman Z
55.62
Beneish M
−2.55
Dividend safety
40/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 6 6 4

+8 more TTM periods

ROE
23.52% 25.04% 24.78% 23.31%
ROA
20.82% 21.85% 21.71% 20.28%
ROIC
40.36% 41.46% 37.60% 37.14%
Return on Tangible Assets
22.65% 23.96% 23.69% 22.09%
Average Days of Receivables
55.77 56.75 59.52 62.83
Free Cash Flow per Share
1.92 1.88 1.30 1.10
Free Cash Flow
24.55 23.97 16.53 13.95
Other line items

Show all line items

Columns are period end dates